Acupuncture for Infectious Mononucleosis Trial (AIM)

University of Alberta

Status and phase: Terminated; Phase 3; Phase 2

Conditions: Infectious Mononucleosis

Treatments: Procedure: traditional Chinese acupuncture; Other: standard medical care

Study type: Interventional

Funder types: Other

Identifiers

NCT00598988

6866

Details and patient eligibility

About

The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Full description

This study examines the feasibility of treating adolescents and young adults diagnosed with infectious mononucleosis with acupuncture. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Enrollment: 3 patients

Sex: All

Ages: 15 to 25 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• mono diagnosis confirmed by lab test
• 21 days or less between start of symptoms and diagnostic test
• presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire)
• no other illnesses present
• meets residency requirement

Exclusion criteria

• insufficient communication in English
• unable to begin acupuncture within 21 days of diagnostic test
• acupuncture use currently or in the preceding 3 months
• currently under the care of a TCM practitioner
• unwilling to be randomized

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

3 participants in 2 patient groups

Acupuncture

Experimental group

Description:

Traditional Chinese acupuncture in conjunction with standard medical care

Treatment:

Procedure: traditional Chinese acupuncture

Standard medical care

Active Comparator group

Description:

standard medical care

Treatment:

Other: standard medical care